Most of us should be familiar with the disease known as Parkinson’s Disease, which ruins countless lives by creating a movement disorder characterized by shaking type of movements. It leads to difficulty moving at all, and in late stages the most common treatments lead to dyskinesthia which is a type of writhing uncontrolled movement. Without detailing the actual nerve pathways, part of the problem is neurodegeneration in a part of the brain called the basal ganglia, in an area known as the Substantia Nigra. When this area is overtaxed and inflamed, a process known as oxidative stress occurs, damaging neurons and created neurofibrous “tangles” known as α-synuclein aggregations.
There is a great deal of research that has been done to detail some natural ingredients that can be used to either prevent, or help treat Parkinson’s. These can sometimes reduce the amount of medication needed, and postpone the onset of dyskinesthia. In some cases successful treatment has occurred and symptoms are gone. The major “theme” of treatment with natural products is to reduce inflammation, block oxidative stress, and promote healthy metabolism in those neuronal cells.
Curcumin is an extract of turmeric, and contains 95% curcuminoids-the active ingredient. This makes it 19 times stronger than turmeric, which only contains 5%. Curcumin has been found to block inflammation, reduce oxidative stress, rescue nerve cells that have been affected, and even to reverse the accumulation of α-synuclein in the brain. I’ve attached a little over two dozen peer-reviewed studies about curcumin and Parkinson’s in the Bibliography. Curcumin is best taken before a meal, and with a tablespoon of coconut oil which boosts absorption and is good for the brain as well.
Another useful herb is Skullcap, Scuttelaria baikalensis, which contains the ingredient Baicalein. This has also been extensively studied for use in treating and reversing some of the effects of Parkinson’s, and is a very promising herb. Note that there aren’t any studies that look at what would happen if you use this AND curcumin, but you can imagine that it should work even better as they do not function through the same mechanisms.
The last strategy I’d like to mention is gut bacteria optimization. As I wrote an entire book about gut bacteria (The Symbiont Factor) I’ll try to be brief. Our gut bacteria wield a big influence on brain and immune function, helping to both tone and control immune function and regulate both the production of neurotransmitters and the sensitivity of neurotransmitter receptor sites in the brain. An imbalance of gut bacteria, which can be assessed with a uBiome.com gut bacteria census, can create functional changes that make the brain less efficient and more inflamed. This sets the stage for Parkinson’s, as neuroinflammation is a required building block of this disease.
Now, you might ask yourselves why this information is not more well known in the Parkinson’s world…it doesn’t actually even appear on the National Parkinson’s Foundation website although many less effective interventions are mentioned. This is because, simply, much of the research is done in search of new drugs to create by copying the action of useful herbs and natural processes. This is one way that companies explore for new drugs that can be patented. The real question is why we would wait for that, when the research shows these natural substances to be quite effective in lab and animal models. Of course, double-blind trials on humans will not be performed until drug candidates are created…so don’t look for the final proof of natural substances, because these trials are very expensive and are only carried out when a candidate drug ($$$) is being evaluated. In other words, follow the money!
Bibliography:
The Symbiont Factor: http://tinyurl.com/z5568ct
Hu Q, Uversky VN, Huang M, Kang H, Xu F, Liu X, Lian L, Liang Q, Jiang H, Liu A, Zhang C, Zhu S.
Biochim Biophys Acta. 2016 Jul 14. pii: S0925-4439(16)30168-5. doi: 10.1016/j.bbadis.2016.07.008. [Epub ahead of print]
- PMID:27425033
Gao L, Li C, Yang RY, Lian WW, Fang JS, Pang XC, Qin XM, Liu AL, Du GH.
Pharmacol Biochem Behav. 2015 Jun;133:155-63. doi: 10.1016/j.pbb.2015.04.004. Epub 2015 Apr 18.
- PMID:25895692
Xue X, Liu H, Qi L, Li X, Guo C, Gong D, Qu H.
Brain Res Bull. 2014 Apr;103:54-9. doi: 10.1016/j.brainresbull.2014.02.004. Epub 2014 Feb 24.
- PMID:24576689
Wang YH, Yu HT, Pu XP, Du GH.
Molecules. 2013 Nov 27;18(12):14726-38. doi: 10.3390/molecules181214726.
- PMID:24288000
Lee E, Park HR, Ji ST, Lee Y, Lee J.
J Neurosci Res. 2014 Jan;92(1):130-9. doi: 10.1002/jnr.23307. Epub 2013 Oct 28.
- PMID:24166733
Zhang Z, Cui W, Li G, Yuan S, Xu D, Hoi MP, Lin Z, Dou J, Han Y, Lee SM.
J Agric Food Chem. 2012 Aug 22;60(33):8171-82. doi: 10.1021/jf301511m. Epub 2012 Aug 9.
- PMID:22838648
[Neuroprotective effect of baicalein in patients with Parkinson’s disease].
Yu X, He G, Du G.
Zhongguo Zhong Yao Za Zhi. 2012 Feb;37(4):421-5. Review. Chinese.
- PMID:22667137
Yu X, He GR, Sun L, Lan X, Shi LL, Xuan ZH, Du GH.
Life Sci. 2012 Jul 26;91(1-2):5-13. doi: 10.1016/j.lfs.2012.05.005. Epub 2012 May 23.
- PMID:22634324
Lu JH, Ardah MT, Durairajan SS, Liu LF, Xie LX, Fong WF, Hasan MY, Huang JD, El-Agnaf OM, Li M.
Chembiochem. 2011 Mar 7;12(4):615-24. doi: 10.1002/cbic.201000604. Epub 2011 Jan 26.
- PMID:21271629
Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration?
Gasiorowski K, Lamer-Zarawska E, Leszek J, Parvathaneni K, Yendluri BB, Błach-Olszewska Z, Aliev G.
CNS Neurol Disord Drug Targets. 2011 Mar;10(2):184-91. Review.
- PMID:21222632
Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.
Hong DP, Fink AL, Uversky VN.
J Mol Biol. 2008 Oct 31;383(1):214-23. doi: 10.1016/j.jmb.2008.08.039. Epub 2008 Aug 23.
- PMID:18775438
The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils.
Zhu M, Rajamani S, Kaylor J, Han S, Zhou F, Fink AL.
J Biol Chem. 2004 Jun 25;279(26):26846-57. Epub 2004 Apr 19.
- PMID:15096521
van der Merwe C, van Dyk HC, Engelbrecht L, van der Westhuizen FH, Kinnear C, Loos B, Bardien S.
Mol Neurobiol. 2016 Mar 22. [Epub ahead of print]
- PMID:27003823
Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats.
Song S, Nie Q, Li Z, Du G.
Pathol Res Pract. 2016 Apr;212(4):247-51. doi: 10.1016/j.prp.2015.11.012. Epub 2015 Nov 18.
- PMID:26922613
Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
Cui Q, Li X, Zhu H.
Mol Med Rep. 2016 Feb;13(2):1381-8. doi: 10.3892/mmr.2015.4657. Epub 2015 Dec 8.
- PMID:26648392
Uğuz AC, Öz A, Nazıroğlu M.
J Recept Signal Transduct Res. 2016 Aug;36(4):395-401. doi: 10.3109/10799893.2015.1108337. Epub 2015 Nov 25.
- PMID:26608462
Ganesan P, Ko HM, Kim IS, Choi DK.
Int J Nanomedicine. 2015 Oct 29;10:6757-72. doi: 10.2147/IJN.S93918. eCollection 2015. Review.
- PMID:26604750
Plant-derived neuroprotective agents in Parkinson’s disease.
Fu W, Zhuang W, Zhou S, Wang X.
Am J Transl Res. 2015 Jul 15;7(7):1189-202. eCollection 2015. Review.
- PMID:26328004
Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice.
Spinelli KJ, Osterberg VR, Meshul CK, Soumyanath A, Unni VK.
PLoS One. 2015 Jun 2;10(6):e0128510. doi: 10.1371/journal.pone.0128510. eCollection 2015.
- PMID:26035833
Tizabi Y, Hurley LL, Qualls Z, Akinfiresoye L.
Molecules. 2014 Dec 12;19(12):20864-79. doi: 10.3390/molecules191220864. Review.
- PMID:25514226
Phom L, Achumi B, Alone DP, Muralidhara, Yenisetti SC.
Rejuvenation Res. 2014 Dec;17(6):481-9. doi: 10.1089/rej.2014.1591.
- PMID:25238331
Tavassoly O, Kakish J, Nokhrin S, Dmitriev O, Lee JS.
Eur J Med Chem. 2014 Dec 17;88:42-54. doi: 10.1016/j.ejmech.2014.07.090. Epub 2014 Jul 25.
- PMID:25081642
Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson’s disease rat.
Yang J, Song S, Li J, Liang T.
Pathol Res Pract. 2014 Jun;210(6):357-62. doi: 10.1016/j.prp.2014.02.005. Epub 2014 Feb 23.
- PMID:24642369
Curcumin protects axons from degeneration in the setting of local neuroinflammation.
Tegenge MA, Rajbhandari L, Shrestha S, Mithal A, Hosmane S, Venkatesan A.
Exp Neurol. 2014 Mar;253:102-10. doi: 10.1016/j.expneurol.2013.12.016. Epub 2013 Dec 29.
- PMID:24382451
Qualls Z, Brown D, Ramlochansingh C, Hurley LL, Tizabi Y.
Neurotox Res. 2014 Jan;25(1):81-9.
- PMID:24122264
The multiple pharmaceutical potential of curcumin in Parkinson’s disease.
Ji HF, Shen L.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):369-73. Review.
- PMID:23844695
Curcumin modulates α-synuclein aggregation and toxicity.
Singh PK, Kotia V, Ghosh D, Mohite GM, Kumar A, Maji SK.
ACS Chem Neurosci. 2013 Mar 20;4(3):393-407. doi: 10.1021/cn3001203. Epub 2012 Dec 17.
- PMID:23509976
Jiang TF, Zhang YJ, Zhou HY, Wang HM, Tian LP, Liu J, Ding JQ, Chen SD.
J Neuroimmune Pharmacol. 2013 Mar;8(1):356-69. doi: 10.1007/s11481-012-9431-7. Epub 2013 Jan 17.
- PMID:23325107
Pan J, Li H, Ma JF, Tan YY, Xiao Q, Ding JQ, Chen SD.
Transl Neurodegener. 2012 Aug 20;1(1):16. doi: 10.1186/2047-9158-1-16.
- PMID:23210631
Agrawal SS, Gullaiya S, Dubey V, Singh V, Kumar A, Nagar A, Tiwari P.
Cardiovasc Psychiatry Neurol. 2012;2012:942981. doi: 10.1155/2012/942981. Epub 2012 Aug
Du XX, Xu HM, Jiang H, Song N, Wang J, Xie JX.
Neurosci Bull. 2012 Jun;28(3):253-8. doi: 10.1007/s12264-012-1238-2.
- PMID:22622825
Ojha RP, Rastogi M, Devi BP, Agrawal A, Dubey GP.
J Neuroimmune Pharmacol. 2012 Sep;7(3):609-18. doi: 10.1007/s11481-012-9363-2. Epub 2012 Apr 21.
- PMID:22527634
Curcumin has neuroprotection effect on homocysteine rat model of Parkinson.
Mansouri Z, Sabetkasaei M, Moradi F, Masoudnia F, Ataie A.
J Mol Neurosci. 2012 Jun;47(2):234-42. doi: 10.1007/s12031-012-9727-3. Epub 2012 Mar 15.
- PMID:
- 22418789
Liu Z, Yu Y, Li X, Ross CA, Smith WW.
Pharmacol Res. 2011 May;63(5):439-44. doi: 10.1016/j.phrs.2011.01.004. Epub 2011 Jan 12.
- PMID:21237271
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson’s disease cell model.
Wang MS, Boddapati S, Emadi S, Sierks MR.
BMC Neurosci. 2010 Apr 30;11:57. doi: 10.1186/1471-2202-11-57.
- PMID:20433710
The Symbiont Factor Blog 